 | Raclopride | Ki | 5.1 [1], 8.7 [2] |
 | Dopamine | IC50 | 15.0 [1] |
 | Haloperidol | IC50 | 5.0 [1] |
 | Apomorphine | IC50 | 25.0 [1] |
 | Harmine | Ki | 10000.0 [1] |
 | Butaclamol | IC50 | 50.0 [1] |
 | 5-OH-Dpat | IC50 | 16.0 [1] |
 | Harmalan | Ki | 10000.0 [1] |
 | Naluzotan | Ki | 2000.0 [1] |
 | Chloroethylnorapomorphine | IC50 | 8000.0 [1] |
 | 6-Methoxyharmalan | Ki | 10000.0 [1] |
 | (S)-1-Propyl-3-(3-propyl-phenyl)-piperidine | Ki | 57.0 [1] |
 | Fluororaclopride | Ki | 159.0 [1] |
 | (S)-3-(3-Ethynyl-phenyl)-1-propyl-piperidine | Ki | 334.0 [1] |
 | (S)-3-(3-Methylsulfanyl-phenyl)-1-propyl-piperidine | Ki | 49.0 [1] |
 | (S)-3-Phenyl-1-propyl-piperidine | Ki | 222.0 [1] |
 | (S)-3-(3-Bromo-phenyl)-1-propyl-piperidine | Ki | 106.0 [1] |
 | 6-Benzyloxymethyl-5-[4-(4-chloro-benzylamino)-phenyl]-pyrimidine-2,4-diamine | IC50 | 33000.0 [1] |
 | Trifluoromethanesulfonic acid 3-[(3S)-1-propyl-3-piperidinyl]phenyl ester | Ki | 40.0 [1] |
 | 3-((S)-1-Propyl-piperidin-3-yl)-benzaldehyde | Ki | 20.0 [1] |
 | Trifluoro-methanesulfonic acid 3-((S)-1-phenethyl-piperidin-3-yl)-phenyl ester | Ki | 11.0 [1] |
 | Toluene-4-sulfonic acid 3-((S)-1-propyl-piperidin-3-yl)-phenyl ester | Ki | 162.0 [1] |
 | [4-[(3S)-1-Propylpiperidin-3-yl]-2-(trifluoromethylsulfonyloxy)phenyl] trifluoromethanesulfonate | Ki | 1100.0 [1] |
 | Trifluoro-methanesulfonic acid 4-((S)-1-propyl-piperidin-3-yl)-phenyl ester | Ki | 1736.0 [1] |
 | (S)-1-Propyl-3-m-tolyl-piperidine | Ki | 430.0 [1] |
 | [(3As,9bR)-3-prop-2-enyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indol-6-yl] trifluoromethanesulfonate | Ki | 1900.0 [1] |
 | Trifluoro-methanesulfonic acid 2-((S)-1-propyl-piperidin-3-yl)-phenyl ester | Ki | 315.0 [1] |
 | 2-[2-[5-[2-(Benzyloxy)phenyl]-3-thienyl]phenyl]cyclopropane-1-carboxylic acid | Ki | 120.0 [1] |
 | 5-(4-(2-Quinolylmethoxy)phenyl)-6-(4-fluorophenyl)pyridine-2(1H)-one | IC50 | 1200.0 [1] |
 | 3,5-Dichloro-N-[[(2S)-1-(4-fluorobutyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide | Ki | 88.5 [1] |
 | 3,5-Dichloro-2-hydroxy-6-methoxy-N-[[(2S)-1-propylpyrrolidin-2-yl]methyl]benzamide | Ki | 17.3 [1] |
 | N-[[(2S)-1-Butylpyrrolidin-2-yl]methyl]-3,5-dichloro-2-hydroxy-6-methoxybenzamide | Ki | 41.1 [1] |
 | 3,5-Dichloro-N-[[(2S)-1-(3-fluorobutyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide | Ki | 2610.0 [1] |
 | 3,5-Dichloro-N-[[(2S)-1-(3-fluoropropyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide | Ki | 130.0 [1] |
 | (3-Prop-2-enyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indol-6-yl) trifluoromethanesulfonate | Ki | 125.0 [1] |
 | (3-Propyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indol-6-yl) trifluoromethanesulfonate | Ki | 89.0 [1] |
 | (4-Propyl-2,3,4a,5,6,10b-hexahydro-1H-benzo[f]quinolin-7-yl) trifluoromethanesulfonate | Ki | 21.0 [1] |
 | 1-[1-[(2-Chlorophenyl)methyl]-2-oxopyridin-3-yl]-3-(3-ethylphenyl)urea | Ki | 10000.0 [1] |
 | N-(4-Aminophenyl)sulfonyl-N'-ethyl-2,3-diazaspiro[4.4]non-3-ene-2-carboximidamide | Ki | 1000.0 [1] |
 | 3,5-Dichloro-N-[[(2R)-1-(3-fluorobutyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide | Ki | 2620.0 [1] |
Calculator
